Can a tiny eye implant tame chronic uveitis Flare-Ups?
NCT ID NCT07423442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 100 adults with non-infectious posterior uveitis, a chronic inflammatory eye disease, who have received a fluocinolone acetonide implant. Researchers will analyze medical records over three years to see how well the implant reduces the frequency and severity of inflammatory relapses and the need for additional treatments. The goal is to better understand the implant's real-world effectiveness and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fluocinolone acetonide implant (a corticosteroid implant placed in the eye)
What this could lead to
If successful, this study could provide real-world evidence that the fluocinolone implant effectively reduces the number and severity of inflammatory flare-ups in people with chronic uveitis, helping to preserve vision.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other treatments or patient differences. The implant is already approved, so this study is about refining its use, not discovering a new cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEITIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Nantes - Ophthalmology Department
Nantes, Nantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••